Quantcast

Latest Abbott Stories

2014-07-10 16:24:57

ABBOTT PARK, Ill., July 10, 2014 /PRNewswire/ -- Today's announcement of a proposed strategic alliance with Fonterra to develop dairy farms is the latest in a series of investments Abbott (NYSE: ABT) has made in China, deepening its commitment in the country. In June, Abbott opened a state-of-the-art nutritional manufacturing facility in Jiaxing, and earlier this year, Abbott opened two research and development centers in Shanghai. In 2014, Abbott has announced more than US$400 million (2.5...

2014-07-10 16:24:52

First Farm Expected to Produce Milk in First Half of 2017 ABBOTT PARK, Ill. and AUCKLAND, New Zealand, July 10, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) and Fonterra Co-operative Group Ltd today announced the signing of an agreement to develop a proposed dairy farm hub in China. The strategic alliance, which is subject to Chinese regulatory approval, will leverage Fonterra's expertise in dairy nutrition and farming in China and Abbott's continued commitment to business development in...

2014-06-25 08:32:15

ABBOTT PARK, Ill., June 25, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2014 financial results on Wednesday, July 16, 2014, before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern), and will be accessible through Abbott's Investor Relations Web site at www.abbottinvestor.com. An archived edition of the call will be available after 11 a.m. Central time. About...

2014-06-24 08:32:02

ABBOTT PARK, Ill., June 24, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Marking (Conformite Europeenne) in Europe for the TECNIS(®) Symfony Extended Range of Vision intraocular lens (IOL) for the treatment of cataract patients who may also have a diminished ability to focus on near objects (presbyopia). Standard IOLs can be used in cataract treatment to improve distance vision, but the TECNIS Symfony IOL is a first-of-its kind lens that is intended to...

2014-06-23 16:25:18

ABBOTT PARK, Ill., June 23, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) today announced a definitive agreement to acquire Veropharm, a leading Russian pharmaceutical manufacturer. Under the terms of the agreement, Abbott will acquire Limited Liability Company Garden Hills, the holding company that currently owns a controlling interest in Veropharm, for between 13.6 billion rubles and 17 billion rubles (or a range of approximately $395 million to $495 million U.S. dollars) depending on...

2014-06-13 12:24:31

ABBOTT PARK, Ill., June 13, 2014 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 22 cents per share. This marks the 362(nd) consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 15, 2014, to shareholders of record at the close of business on July 15, 2014. Abbott has increased its dividend payout for 42 consecutive years and is a member of the S&P 500 Dividend Aristocrats...

2014-06-04 08:33:28

ABBOTT PARK, Ill., June 4, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the William Blair 34(th) Annual Growth Stock Conference on Wednesday, June 11, 2014. Thomas C. Freyman, executive vice president, finance and chief financial officer, will present at 4:40 p.m. Central time. A live audio webcast of the presentation will be accessible through Abbott's Investor Relations Web site at www.abbottinvestor.com. An archived edition of the presentation will be available later...

2014-05-16 08:25:59

Abbott enhances its position in fast-growing Latin American market, more than doubling its branded generics pharmaceutical sales and presence in the region ABBOTT PARK, Ill., May 16, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) today announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence and further expanding Abbott's presence in fast-growing markets. Under the...

2014-05-12 08:32:13

- Early study results suggest Abbott technology equivalent to current standard of care, but produces results much more quickly BARCELONA, Spain, May 12, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) today announced initial results that suggest its innovative testing platform, known as IRIDICA (currently in development), produces results consistent with the current standard of care in just hours. Currently, the diagnosis of serious infections, such as sepsis or pneumonia, can often take...

2014-05-08 08:34:31

Clonmel, Ireland, Facility is the First Site in Europe to Receive the Prestigious Shingo Prize ABBOTT PARK, Ill., May 8, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) has been awarded the Shingo Prize, an international award for operational excellence, by the Shingo Institute at the Jon M. Huntsman School of Business at Utah State University. Abbott's vascular devices manufacturing facility in Clonmel, Ireland, received the award, recognizing the site's initiative to develop and maintain...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related